Serum levels of MCP-1 , eotaxin-1 , MIP-1 , C reactive protein ( CRP ) and interleukin-6 ( IL-6 ) were measured in lean control and metabolic syndrome subjects at baseline , and following a 6-week randomized placebo-controlled clinical trial of atorvastatin ( 10 mg/d ) .
